Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · IEX Real-Time Price · USD
1.47 -0.08 (-5.16%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap214.66M
Revenue (ttm)n/a
Net Income (ttm)-24.51M
Shares Out146.03M
EPS (ttm)-0.23
PE Ration/a
Forward PE1.29
Dividendn/a
Ex-Dividend Daten/a
Volume2,244,497
Open1.55
Previous Close1.55
Day's Range1.45 - 1.56
52-Week Range1.15 - 4.56
Beta1.45
AnalystsBuy
Price Target6.67 (+353.7%)
Earnings Daten/a

About CTXR

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections followin...

IndustryPharmaceuticals
Founded2007
CEOMyron Holubiak
Employees15
Stock ExchangeNASDAQ
Ticker SymbolCTXR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for CTXR stock is "Buy" and the 12-month stock price forecast is 6.67.

Price Target
$6.67
(353.74% upside)
Analyst Consensus: Buy

News

Citius Pharmaceuticals, Inc. to Present at Upcoming Virtual Conferences

CRANFORD, N.J., Jan. 4, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...

2 weeks ago - PRNewsWire

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2021 Financial Results and Provides Business Update

CRANFORD, N.J., Dec. 15, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commerciali...

1 month ago - PRNewsWire

Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the ...

CRANFORD, N.J., Dec. 6, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...

1 month ago - PRNewsWire

Citius Pharmaceuticals Expands Management Team with Appointment of Kelly Creighton, PhD as Executive Vice President o...

CRANFORD, N.J., Nov. 5, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...

2 months ago - PRNewsWire

Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters ...

CRANFORD, N.J., Oct. 25, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commerciali...

2 months ago - PRNewsWire

Top Penny Stocks to Add to Your Watchlist This Week

Which penny stocks are on your watchlist for this coming week? The post Top Penny Stocks to Add to Your Watchlist This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc...

Other symbols:BORRCSCW
3 months ago - PennyStocks

Citius Pharmaceuticals to Host Investor Webcast to Discuss the Acquisition of Late Phase 3 Cancer Immunotherapy I/ONT...

CRANFORD, N.J., Oct. 13, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that it will host a webcast on October 20, 2021 at 8:30 a.m.

3 months ago - PRNewsWire

Citius Pharmaceuticals to Present at Upcoming October Investor Conferences

CRANFORD, N.J., Oct. 6, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...

3 months ago - PRNewsWire

Temple University Renames College of Liberal Arts Main Campus Building in Honor of Citius Pharmaceuticals Executive C...

CRANFORD, N.J., Oct. 1, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...

3 months ago - PRNewsWire

Citius Pharmaceuticals to Join Benzinga All Access Show on Friday, September 17, 2021

CRANFORD, N.J., Sept. 14, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of ...

4 months ago - PRNewsWire

Citius Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15

CRANFORD, N.J., Sept. 8, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of f...

4 months ago - PRNewsWire

Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for...

CRANFORD, N.J., Sept. 7, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that it has entered into a definitive agreement with Dr. Reddy's Lab...

Other symbols:RDY
4 months ago - PRNewsWire

Best Penny Stocks For Your Buy List in September? 3 To Watch

With September only a day away, which penny stocks are on your buy list? The post Best Penny Stocks For Your Buy List in September?

Other symbols:BLINKOS
4 months ago - PennyStocks

Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update

CRANFORD, N.J., Aug. 12, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of f...

5 months ago - PRNewsWire

Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs

Image by falco from Pixabay What happens when the one product keeping you alive becomes infected?

5 months ago - Benzinga

Best Reddit Penny Stocks to Buy in August? 3 For Your List

There's a reason that so many investors like Reddit penny stocks; here's 3 for your list The post Best Reddit Penny Stocks to Buy in August? 3 For Your List appeared first on Penny Stocks to Buy, Picks,...

Other symbols:ENDP
6 months ago - PennyStocks

Could Citius Pharmaceuticals Be a Millionaire-Maker Stock?

A lot would have to go right for this biotech to make investors rich.

6 months ago - The Motley Fool

3 Penny Stocks That Are Popular With Reddit Traders Right Now

These Reddit Penny Stocks Are Rising in Popularity Right Now; Are They Worth It or Not? The post 3 Penny Stocks That Are Popular With Reddit Traders Right Now appeared first on Penny Stocks to Buy, Pick...

Other symbols:CSCWSOS
6 months ago - PennyStocks

7 Top-Rated Pharmaceutical Companies to Invest In for July

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest In ...

6 months ago - InvestorPlace

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Citius Pharmaceuticals, Inc. - CTXR

NEW YORK, July 7, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Citius Pharmaceuticals, Inc. ("Citrus" or the "Company") (NASDAQ: CTXR).  Such investors are advise...

6 months ago - PRNewsWire

Making a List of Penny Stocks to Buy? Here's 7 to Watch in Summer 2021

Does your list of penny stocks to watch include these 7 hot small-caps? The post Making a List of Penny Stocks to Buy?

6 months ago - PennyStocks

Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones

CRANFORD, N.J., July 7, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of fi...

6 months ago - PRNewsWire

Are Options Traders Betting on a Big Move in Citius Pharmaceuticals (CTXR) Stock?

Investors need to pay close attention to Citius Pharmaceuticals (CTXR) stock based on the movements in the options market lately.

6 months ago - Zacks Investment Research

Here's Why Citius Pharmaceuticals Stock Is Losing Ground Today

Another interim analysis has come and gone with an unsatisfying result.

6 months ago - The Motley Fool

Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue t...

CRANFORD, N.J., July 1, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of fi...

6 months ago - PRNewsWire